• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
FinanceInsider trading

Ex-Bank of New York Mellon employee pleads guilty to insider trading

By
Reuters
Reuters
Down Arrow Button Icon
By
Reuters
Reuters
Down Arrow Button Icon
October 24, 2014, 5:43 PM ET
Stock Open Slightly Higher On The New York Stock Exchange
NEW YORK - AUGUST 15: A woman walks by the New York Stock Exchange (NYSE) on Wall St. August 15, 2008 in New York City. Stocks were up in morning trading on Wall Street as the strengthening U.S. dollar drove global commodity prices down. (Photo by Spencer Platt/Getty Images)Photo by Spencer Platt—Getty Images

A former Bank of New York Mellon Corp employee on Friday pleaded guilty to insider trading based on tips from a former Merck & Co Inc employee about potential pharmaceutical mergers.

Federal prosecutors in New York said David Post, 41, a product manager at the bank, received nonpublic information from a former Rutgers Business School classmate about three companies: Idenix Pharmaceuticals, Ardea BioSciences and ViroPharma Inc.

Prosecutors did not name the classmate, but on Oct. 14 they charged Zachary Zwerko, a former senior finance analyst with Merck, with passing inside tips about the same three stocks to a Rutgers classmate who worked at a bank.

The connection was confirmed when the U.S. Securities and Exchange Commission on Friday amended a parallel civil complaint against Zwerko to include Post as a defendant.

Ron Gruendl, a spokesman for Bank of New York Mellon, said Post’s conduct was not connected to his work at the bank.

“We have cooperated fully with law enforcement and regulatory agencies,” he said. “He is no longer employed here.”

According to criminal and civil court filings, Zwerko passed information to Post about Merck’s acquisition of Idenix as well as Ardea and ViroPharma, which Zwerko learned were potential acquisition targets. Post then traded on the information and split the profits with Zwerko, authorities said. AstraZeneca PLC announced a bid for Ardea in April 2012, while Shire PLC announced a takeover of ViroPharma in November 2013.

“Post and Zwerko tried to keep law enforcement authorities in the dark by using prepaid cell phones and a dummy e-mail account to communicate inside information, and Post doled out the kickbacks inside his own home,” Sanjay Wadhwa, senior associate director of the SEC’s New York regional office, said in a statement.

At a court hearing before U.S. District Judge Alvin Hellerstein, a tearful Post admitted he executed a series of trades between 2012 and 2014 based on the tips.

He entered a guilty plea to one count of conspiracy and three counts of securities fraud as part of a cooperation agreement with the Manhattan U.S. Attorney’s office.

Assistant U.S. Attorney Jessica Masella said in court that Post is believed to have earned more than $700,000 in illicit profits.

Post, a resident of Livingston, New Jersey, is scheduled to be sentenced in January and faces up to 20 years in prison on each securities fraud count and up to 5 years on the conspiracy charge, although a maximum sentence is unlikely.

About the Author
By Reuters
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.